{
    "Trade/Device Name(s)": [
        "Kappa light chains Assay"
    ],
    "Submitter Information": "SENTINEL CH SpA",
    "510(k) Number": "K083602",
    "Predicate Device Reference 510(k) Number(s)": [
        "K964260"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DFH"
    ],
    "Summary Letter Date": "August 26, 2009",
    "Summary Letter Received Date": "August 31, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.5550"
    ],
    "Regulation Name(s)": [
        "Immunoglobulin (light chain specific) immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Kappa light chains"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Li-heparin plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Synchron LX20 System"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for SENTINEL CH Kappa light chains assay for quantitative determination of kappa light chains in serum and Li-heparin plasma using immunoturbidimetry on Synchron LX20 System",
    "Indications for Use Summary": "In vitro diagnostic test for quantitative determination of immunoglobulin bound and free kappa light chains in serum and Li-heparin plasma, aiding diagnosis of multiple myeloma, lymphocytic neoplasms, Waldenstrom's macroglobulinemia, and connective tissue diseases with other clinical and laboratory findings",
    "fda_folder": "Immunology"
}